ISTH 2021 Congress Archives - ISTH Congress Abstracts

Abstract Number: PB0848

Validating Lactate Dehydrogenase (LDH) as a Component of the PLASMIC Predictive Tool (PLASMIC-LDH)

C.C.K. Liam^1,2,3, J.Y.-H. Tiao^1,2, Y.Y. Yap³, J. Sathar³, Y.L. Lee⁴, S. McRae⁵, A. Davis⁶, J. Curnow⁷, R. Bird⁸, P. Choi⁹, P. Angchaisuksiri¹⁰, S.L. Tien¹¹, J.C.M. Lam¹², D. Oh¹³, J.S. Kim¹⁴, S.-S. Yoon¹⁵, R. Wong¹⁶, S. Macpherson^17,18, E. Merriman^19,20, R.I. Baker^1,2
Abstract Number: PB0798

Validation of a de novo Paediatric Warfarin Nomogram

S. Jones^1,2,3, P. Monagle^1,4,3, A. Allan², S. Chen², K. Dawson², A. Kuzmitsky², M. Pham-Crepps², E. Renner-Hahn², A. Greenway¹, F. Newall^1,2,3
Abstract Number: PB0100

Validation of a New Kit for the Quantitative Determination of Chromogenic Factor IX Activity

T. Quinton¹, R. Clarke¹, J. Fraser¹, K.M Black¹, A. Sadeghi-Khomami¹
Abstract Number: PB0382

Validation of Mixing Test Formula for the Discrimination between Lupus Anticoagulant and Acquired Hemophilia A in New APTT Reagent

O. Kumano¹, D. Shimomura², K. Kitano¹, N. Arai¹, T. Matsumoto³.
Abstract Number: PB0126

Validation of the Bioequivalence of USP Potency Adjusted Porcine, Ovine and Bovine Heparins

N. Baig¹, M. Jaradeh¹, A. Kouta¹, W. Jeske¹, D. Hoppensteadt¹, J. Walenga¹, O. Iqbal¹, F. Siddiqui¹, M. Bakhos¹, J. Fareed¹
Abstract Number: LPB0137

Validation of the HULL Clinical Prognostic Rule (CPR) for Incidental Pulmonary Embolism in Ambulatory Cancer Patients

F. Haque^1,2, G. Bozas¹, C. Huang², A. Pillai¹, S. Mirza¹, J. Ryde¹, S. Sethi¹, M. Kolodziej¹, A. Stephens¹, S. Raper¹, E. Gollins¹, G. Avery^1,2, A. Maraveyas^1,2
Abstract Number: PB0257

Value of Laboratory Parameters in the Clinical Monitoring of Patients with SARS-COV-2 Infection (COVID-19)

M. Moreno Carbonell¹, A. Gómez Martínez¹, C. Hernández Mata¹, E. González Gómez¹, S. Martín-Consuegra Ramos¹, M. Civeira Marín¹, A. López Peña¹, C. Rodríguez Lefler¹, A.J. García Ortego¹, S.F. Pinzón Mariño², N. Fernández Mosteirin¹, J.M. Calvo Villas¹
Abstract Number: PB0854

Variable Serotonin Release Assay Pattern and Characteristics of PF4-specific Antibodies in Heparin-Induced Thrombocytopenia, and Clinical Impact

N. Charuel^1,2, J. Rollin^1,3, Y. Gruel^1,3, E.-A. Guéry³, M.-A. May^4,5, C. Pouplard^1,3, C. Vayne^1,3
Abstract Number: PB0114

Various Receptors Are Related with the APC-induced Suppression of Osteoclast Differentiation

N. Akita¹, K. Yoshida², T. Okamoto³, K. Asanuma⁴, K. Suzuki¹, T. Hayashi⁵
Abstract Number: PB0931

Vascular Abnormalities in Patients with Von Willebrand Disease: A Scoping Review

N. Chornenki¹, M. Shanjer², P. James¹
Abstract Number: OC 68.4

Vascular Endothelial Damage in the Pathogenesis of Preeclampsia and SARS-CoV-2 Infection in Pregnancy

M. Palomo¹, S. Torramadé-Moix², A.B. Moreno-Castaño², J. Martinez-Sanchez³, L. Bonastre², M. Pino², P. Sanchez⁴, L. Youssef⁵, F. Crovetto⁵, G. Escolar², E. Carreras⁶, P. Castro⁷, E. Gratacós⁵, F. Crispi⁵, M. Diaz-Ricart²
Abstract Number: PB0261

Venous Thromboembolic Disease in Patients Wwith SARS-CoV2 Infection: In Search of a Predictive Biomarker

P. Silva de Tena¹, R. Gómez de Antonio¹, R.M. Martín Rojas¹, G. Perez Rus^1,2,3, J.L. Díez-Martín^1,2,3, C. Pascual Izquierdo^1,2,3
Abstract Number: PO182

Venous Thromboembolism as the First Presentation of Multiple Myeloma

X. Ye¹
Abstract Number: PO194

Venous Thromboembolism in a 30 Year Old Female: Synergic Effect of Oral Contraceptive and Elevated Factor VIII?

F. Laouan Brem¹, F. Mouedder¹, C. Toutai¹, N. Ismaili^1,2, N. El Ouafi^1,2
Abstract Number: PB0225

Venous Thromboembolism in Cancer Patients with SARS-CoV-2 Infection

D. Attia¹, W. Wei², M. Wilks¹, B. Tripp¹, C. D’Andrea¹, D.E. Angelini¹, A.A. Khorana¹
Abstract Number: PB1117

Venous Thromboembolism in Children with Acute Lymphoblastic Leukemia in China: A Multi-center Clinical Study

M. Yin¹, H. Wang², J. Yu³, J. Gao⁴, M. Yang⁵, N. Wang⁶, T. Liu⁷, S. Shen⁸, A.W. Leung⁹, F. Zhou¹⁰, X. Wu¹¹, J. Huang¹², H. Li¹³, S. Hu¹⁴, X. Tian¹⁵, H. Jiang¹⁶, X. Zhai², J. Tang⁸, Q. Hu¹
Abstract Number: OC 25.2

Venous Thromboembolism in Critically-ill Patients with Pneumonia in the Pre-COVID-19 Era: Data from a Large Public Database

M.P.L. Ferreira¹, S. Barco², J.M Annichino-Bizzacchi^3,1, E.V De Paula^3,1, F.A. Orsi¹
Abstract Number: PB0171

Venous Thromboembolism in Hospitalized Critical and Non-critical COVID-19 Patients: A Systematic Review and Meta-analysis

E. Mansory^1,2, S. Srigunapalan¹, A. Lazolangner¹
Abstract Number: PB1192

Venous Thromboembolism in Patients Hospitalized with COVID-19: Results from the Brazilian COVID-19 Registry

W.C. Silveira¹, S.M. Rezende¹, M.A.P. Martins¹, M.C. Pires¹, R.T. Silva¹, L.E.F. Ramos¹, M.V.R.S. Silva¹, T.L.S. Sales², C.C.R. Cimini³, M.H. Guimarães Júnior⁴, F.G. Aranha⁵, M.C.A. Nogueira⁶, L.B. Moreira⁷, T.O. Fereguetti⁸, P.L. Assaf⁹, M. Carneiro¹⁰, M.S. Marcolino¹, S.F. Araújo¹¹, A.V. Schwarbold¹², G.A.N. Bastos¹³
Abstract Number: PB1215

Venous Thromboembolism Profile and Management Differences between Ages in a RIETE’s Hospital of Brazil

R. Santos de Oliveira Júnior¹, J. Abreu Couto Vieira¹, A.T. Cavalcanti Rocha¹
Abstract Number: PO173

Venous Thromboembolism Prophylaxis during Hospitalization: Evidence-based Recommendation (by an Internal Medicine Team)

F.J. Vázquez¹, M.F. Grande Ratti¹, M.G. Vallone¹, P.G. Paula Guadalupe Gutierrez¹, M.B. Bonella¹, D. Andresik¹, A. Freixas¹, M.L. Peroni¹, D.S. Thomas¹, C.M.U. Ungaro¹, M. Burgos¹, D.H. Giunta¹, H.M. Recchioni¹, M.M. Serra¹, B. Martinez¹, H. Michelangelo¹, J.A. Pollán¹, B.R. Boietti¹, V.A. Peuchot¹
Abstract Number: PB1228

Venous Thromboembolism Prophylaxis in Patients with Severe Burns in a Large Trauma Hospital

R. Brazilek¹, H. Cleland¹
Abstract Number: PB1225

Venous Thromboembolism Risk Profiles and Prophylaxis in Medical Oncology Inpatients: a Subgroup Analysis of the Observational DissolVE-2 Study

R. Xu¹, Y. Shi², Y. Gao³, Z. Zhai⁴, W. Li⁵, X. Qin⁶, J. Qu⁷, C. Wang⁴
Abstract Number: PB1120

Venous Thromboembolisms are Significantly Associated with Central Venous Catheter Loss in Pediatric Cancer Patients

Z. Forbrigger¹, P. Moorehead², K. Kulkarni³
Abstract Number: PB0092

Viscoelastic Haemostatic Assay Comparison for Perioperative Coagulation Assessment

J. Fanning^1,2,3, S. Roberts^4,1, C. Anstey⁵, K. Poon^3,6, A. Incani^3,1, J. Fraser^2,1,3
Abstract Number: PB0877

Vitamin B-12 Deficiency and Pseudo Thrombotic Microangiopathy: A Case Series

C. Jones¹, R. Kumar²
Abstract Number: PB1143

VKORC1 -1639AA Genotype Is a Possible Protective Factor for Venous Thromboembolism Development in Patients with FII G20210A Mutation from North-Western Russia

S. Kapustin¹, A. Chechulova², S. Svitina¹, J. Sidorova¹, V. Burakov¹, V. Soroka², V. Soldatenkov¹, L. Papayan¹
Abstract Number: OC 46.4

VMX-C001 Is an Effective FXa-DOAC Reversal Agent and Displays No Thrombogenic Potential in Comparison to Andexanet Alfa and 4PCC

D. Verhoef^1,2, T. Gomes¹, G. Short¹, P.H. Reitsma^1,2
Abstract Number: PB0930

Von Willebrand Factor (VWF) Collagen IV Binding Defect – A Potentially Overlooked Cause for Excessive Bleeding Phenotype

M. Escobar¹, N. Montanez¹, J. Lemons¹, K. Friedman²
Abstract Number: PB0915

von Willebrand Factor (VWF) Multiplex Activity Assay Differentiation of Low VWF/Type 1 von Willebrand Disease (VWD) and Variant VWD: Analysis from the Comparative Effectiveness in the Diagnosis of VWD

J.C. Roberts¹, P.A. Christopherson², M.D. Tarantino¹, S.E. Gonzales¹, P.A. Morateck², C.L. Perry², V.H. Flood², T.C. Abshire², R.R. Montgomery², Z.P. Investigators²
Abstract Number: PB0166

Von Willebrand Factor and ADAMTS13 Activity as Endothelial Injury Markers and their Prognostic Value in COVID-19

A. Marco^1,2, P. Marco^1,2,3
Abstract Number: OC 66.3

Von Willebrand Factor Contributes to Alternative Complement Pathway Activation, Microangiopathy, and Renal Dysfunction in Murine Thromboinflammation

P. Jacobi^1,2, S. Sartain^1,2
Abstract Number: PO158

Von Willebrand Factor Multimer Distribution Analysis in a Group of Patients Diagnosed with von Willebrand Disease

E. Wojtasinska¹, O. Krupinska¹, M. Malachowska¹, A. Szczepaniak¹, J. Rupa-Matysek¹, L. Gil¹
Abstract Number: PB0743

Von Willebrand Factor Propeptide to Antigen Ratio: Evidence of Endothelial Activation in HIV Infected Pregnancy

E. Schapkaitz¹, E. Libhaber¹, B. Jacobson¹, M. Meiring², H. Büller³
Abstract Number: PB0792

VTE Incidence in Children with Different Blood Disorders: Data from a Large Monocenter Retrospective Cohort Study

P.A Zharkov¹, D.A Evstratov¹, K.A Voronin¹, D.V Fedorova¹, A.V Pshonkin¹
Abstract Number: PB1220

VTE Prophylaxis in Foot and Ankle Surgery: A Worldwide Survey

R. Zambelli^1,2, S. Frolke³, B. Nemeth⁴, D. Baumfeld², C. Nery⁵, C. Ortiz⁶, S. Cannegieter⁴, S. Rezende²
Abstract Number: PB1234

VTE Risk at Discharge

K. Patel¹, R. Fulton¹, J. Knapp¹, T. Knox¹, H. Lombardo¹, M. Lóser¹, A. Hallam², A. Macchiavelli^1,2
Abstract Number: PB1257

VTE Treatment Planning: A Mixed-method Analysis of Clinical Challenges, Knowledge, and Confidence Gaps in Selecting Evidence-based Treatment

A. Spyropoulos¹, P. Lazure², S. Kaatz³, A. Khorana⁴, S. Zahabi², K. McCrae⁴, C. Pollack⁵, S. Péloquin²
Abstract Number: OC 11.1

VWF-bound GPIbα under Flow Activates Human Platelet TF and Surface-bound FVII, Sparking Clotting Reactions, Thrombin Generation and Fibrin Deposition

O. Panes¹, M.F. Becerra¹, R. Valle², C.G. Sáez¹, P. Hidalgo¹, J. Pereira¹, J. Royce³, D. Pedrosa⁴, W. Ruf^4,5, D. Mezzano¹